Big Move For Ardelyx, Inc.
Ardelyx, Inc. (ARDX:NASDAQ) shot up at $1.72, representing a gain of 41%. On Thu, Nov 17, 2022, ARDX:NASDAQ hit a New 2-Week High of $1.72. The stock got featured on our News Catalysts scanner on Thu, Nov 17, 2022 at 12:37 PM in the 'BIOTECH' category. From Thu, Nov 03, 2022, the stock recorded 30.00% Up Days and 9.09% Green Days
About Ardelyx, Inc. (ARDX:NASDAQ)
Ardelyx Inc is a clinical stage biopharmaceutical company. It engages in the discovery, development and commercialization of non-systemic, molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal and metabolic diseases.
Top 10 Gainers:
- SatixFy Communications Ltd. (SATX:NYSEMKT), 96.35%
- Elevate Credit, Inc. (ELVT:NYSE), 68.87%
- Ardelyx, Inc. (ARDX:NASDAQ), 40.98%
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 32.23%
- Atour Lifestyle Holdings Limited (ATAT:NASDAQ), 30.99%
- XL Group Ltd (XL:NYSE), 30.91%
- NWTN Inc. (NWTN:NASDAQ), 29.75%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- GoHealth Inc. (GOCO:NASDAQ), 26.5%
- Conformis, Inc. (CFMS:NASDAQ), 26.4%